Increased CD14+HLA-DR-/low myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome

CD14+HLA-DR-/low髓源性抑制细胞增多可被视为急性冠脉综合征中疾病严重程度和治疗反应的生物标志物。